Computed Tomography in the Postoperative Surveillance of Stage III Colorectal Cancers Receiving Adjuvant Chemotherapy
نویسندگان
چکیده
Ping-Fu Yang Chau-Yun Chen Li-Chun Kao Cheng-Jen Ma Fang-Ming Chen Hon-Man Chan Che-Jen Huang Jan-Sing Hsieh Jaw-Yuan Wang Division of Gastroenterology and General Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Department of Radiology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Department of Radiology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Cancer Center, Kaohsiung Medical University Hospital, Department of Medical Genetics, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
منابع مشابه
Factors Affecting Use and Delay (≥8 Weeks) of Adjuvant Chemotherapy after Colorectal Cancer Surgery and the Impact of Chemotherapy-Use and Delay on Oncologic Outcomes
PURPOSE To evaluate factors affecting the use and delay ≥8 weeks of adjuvant chemotherapy and the impact of chemotherapy use and delay on survival. METHODS Between 2005 and 2012, consecutive patients with stage II and III colorectal cancer who were treated with major curative resection were enrolled. RESULTS Among 750 patients with stage II (n = 318) and III (n = 432) disease, 153 (20.4%) d...
متن کاملPrognostic Impact of Changes in Adipose Tissue Areas after Colectomy in Colorectal Cancer Patients
There have been few studies assessing the changes in the body components of patients after colectomy in colorectal cancer (CRC). The purpose of this study was to verify the trends in the adipose tissue areas of CRC patients before and after surgery and to determine their clinical relevance. Computed tomography (CT)-assessed subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) are...
متن کاملGALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy
Adjuvant oxaliplatin-based chemotherapy is widely used for stage III colorectal cancer (CRC) after curative surgery. CRC is a molecularly heterogeneous disease, and our current knowledge of therapeutic response-related genetic factors remains limited. N-acetylgalactosaminyltransferase 14 (GALNT14)-rs9679162 genotype is a prognostic predictor for chemotherapy response in advanced hepatocellular ...
متن کاملPrognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials
BACKGROUND AND OBJECTIVE Studies examining the prognostic value of the BRAF mutation on relapse-free survival (RFS), disease-free survival (DFS) and overall survival (OS) in stage II/III colorectal cancer (CRC) patients receiving curative resection and adjuvant chemotherapy so far showed discrepant results. Therefore, a meta-analysis of relevant studies was performed for clarification. METHOD...
متن کاملPathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
BACKGROUND Although there are controversies regarding the benefit of fluoropyrimidine-based adjuvant chemotherapy in patients with microsatellite instability-high (MSI-H) colorectal cancer (CRC), the pathologic features affecting postchemotherapeutic prognosis in these patients have not been fully identified yet. METHODS A total of 26 histopathologic and immunohistochemical factors were compr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2012